MTaI welcomes government’s decision to create NMDPC
MTaI backs NMDPC, urging fair Make-in-India opportunities so global firms can invest, boost FDI, and expand quality medical device access for Indian patients.
Read More
MTaI seeks one time increase of 18% in MRP of medical device
MTaI urges govt to allow a one-time 18% MRP hike on medical devices to offset rupee depreciation, inflation, and ensure uninterrupted supply.
Read More
AN IDEAL ROADMAP TO STRENGTHEN MEDTECH IN INDIA
India’s medtech needs a clear roadmap—separate from drugs, nuanced regulation, R&D incentives, export focus, and smart pricing—to unlock Ayushman Bharat’s poten
Read More
Create A Level-Playing Field For Importers Vis-à-Vis Local Manufacturers
NPPA data shows hospitals—not device makers—drive high costs. Trade Margin Rationalization should be PTT-based; cost-based models distort markets and innovation
Read More
MedTech – Vitalizing Ayushman Bharat
Experts say Ayushman Bharat’s success hinges on strong MedTech support, skilled manpower, fair pricing, PPPs, and balanced regulation.
Read More
MTaI points out ill-information on needles, syringes pricing
MTaI says NPPA issued no advisory on syringe margins, defends members, and reiterates support for uniform trade margin rationalisation.
Read More
The many challenges ahead of Ayushman Bharat
Ayushman Bharat promises universal care, but experts warn quality, pricing, and execution challenges may slow its real impact.
Read More
Medical tech industry associations join hands to partner with Ayushman Bharat scheme
MedTech industry bodies at MTaI MedTekon 2018 pledged support to strengthen Ayushman Bharat and reduce out-of-pocket healthcare costs.
Read More
Standardisation for medical devices; nearly 1,000 products
MedTech industry bodies at MTaI MedTekon 2018 pledged support to strengthen Ayushman Bharat and reduce out-of-pocket healthcare costs.
Read More